Although an increasing incidence of upper extremity venous thrombosis (U/E-
DVT) has been reported, a relative paucity of information regarding the eti
ologic categories, precipitating causes, and proper management for this dis
order is available. To settle on a strategy for the management of U/E-DVT,
retrospective analyses were performed using records from the authors' hospi
tal. In 12 patients (seven men, five women), 61 (mean) years of age, diagno
sed as having symptomatic venography-proved U/E-DVT and followed up for 41
(mean) months, etiologic factors, precipitating causes, treatments, and out
comes were retrospectively analyzed. As etiologic factors, five of the pati
ents had neoplastic disease, one had hemodialysis, and two had transvenous
pacemaker implantations. Among various precipitating causes of U/E-DVT, hyp
oproteinemia was most frequently noted (67%). Various types of therapeutic
management were selected: from thrombolysis with urokinase in six, balloon
angioplasty in two, thrombectomy in two, and venous bypass surgery in one p
atient. Pulmonary embolism did not occur in any of the patients and only th
ree of them complained of mild intermittent arm swelling during the follow-
up period. Four patients died of neoplastic disease or heart failure (three
within the first 6 months).
This study, though limited, suggests that the rate of mortality depends on
multiple underlying medical problems in U/E-DVT patients. Low incidences of
late postthrombotic sequelae and pulmonary embolism were noted in this ser
ies. Symptomatic U/E-DVT patients could be managed conservatively with a re
vised supplementary therapy for their precipitating causes of U/E-DVT.